QuickView for PE-2;jsessionid=CA18351BF2FAF14057123EB724F8B4AC;jsessionid=594246C8B2782AB80CBC615C11A7EDDA;jsessionid=D061674B14DDD9647A041FA65D2C1769;jsessionid=91CD1B1B1B65EA2C5E5898DDE173D0B7 (gene)

1. The Ets2 Repressor Factor (Erf) Is Required for Effective Primitive and Definitive Hematopoiesis.
2. Noonan syndrome-like phenotype in a patient with heterozygous ERF truncating variant.
3. Structure-Activity Relationship Study of Antimicrobial Peptide PE2 Delivered Novel Linear Derivative…
4. Generation of a more efficient prime editor 2 by addition of the Rad51 DNA-binding domain.
5. Deletion of ERF and CIC causes abnormal skull morphology and global developmental delay.

There were no clinical trials for PE-2;jsessionid=CA18351BF2FAF14057123EB724F8B4AC;jsessionid=594246C8B2782AB80CBC615C11A7EDDA;jsessionid=D061674B14DDD9647A041FA65D2C1769;jsessionid=91CD1B1B1B65EA2C5E5898DDE173D0B7